|
10
|
|
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Sun HC
…
Fan J
The Lancet
2026-08-22
|
#hepatocellular carcinoma
#immunotherapy
#surgery
#clinical trial
#oncology
|
|
8
|
|
Hepatocellular carcinoma organoids enable drug discovery and combination therapy across heterogeneous tumors.
(linkinghub.elsevier.com)
|
Nuciforo S
…
Heim MH
Cell Reports
2026-08-24
|
#organoid
#hepatocellular carcinoma
#drug discovery
#combination therapy
#heterogeneity
|
|
4
|
|
Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Hu C
…
Chen Y
Cancer Cell
2026-08-17
|
#immunotherapy
#hepatocellular carcinoma
#microbiome
#immunity
#spatial omics
|
|
2
|
|
Adjuvant and neoadjuvant therapies in HCC: Time to go perioperative?
(linkinghub.elsevier.com)
|
Pantzios S
…
Elefsiniotis I
iScience
2026-08-21
|
#hepatocellular carcinoma
#immunotherapy
#neoadjuvant
#adjuvant
#checkpoint-inhibitors
|
|
0
|
|
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Yu H
…
Lu Y
Drug Resistance Updates
2026-08-12
|
#hepatocellular carcinoma
#immunotherapy
#targeted therapy
#treatment-resistance
#oncology
|
|
0
|
|
Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC.
(linkinghub.elsevier.com)
|
Yang Y
…
Liu B
Cell Reports
2026-08-08
|
#chromatin
#hepatocellular carcinoma
#stemness
#epigenomics
#immunity
|
|
0
|
|
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.
(gut.bmj.com)
|
Gorgulho J
…
von Felden J
Gut
2026-08-06
|
#liquid biopsy
#immunotherapy
#hepatocellular carcinoma
#biomarker
#extracellular vesicles
|
|
0
|
|
Non-canonical mTORC1-TFEB activation promotes hepatocyte plasticity and high-grade malignancy in hepatocellular carcinoma.
(jci.org)
|
Zhang C
…
Ding WX
Journal of Clinical Investigation
2026-08-06
|
#hepatocellular carcinoma
#plasticity
#metabolism
#transcriptomics
#signaling
|
|
0
|
|
Co-phase separation of KRI1 and NPM1 sustains nucleolar integrity and ribosome biogenesis to fuel liver cancer progression.
(pnas.org)
|
Lu Y
…
Wen W
PNAS
2026-08-03
|
#hepatocellular carcinoma
#phase separation
#ribosome biogenesis
#nucleolus
#protein-protein interaction
|
|
0
|
|
Enhanced acetate uptake and metabolism in endothelial cells promote tumour angiogenesis and immunosuppression by increasing histone acetylation.
(gut.bmj.com)
|
Chen JY
…
Zhuang SM
Gut
2026-07-31
|
#angiogenesis
#immunosuppression
#metabolism
#hepatocellular carcinoma
#epigenetics
|
|
0
|
|
A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms.
(linkinghub.elsevier.com)
|
Wang S
…
Yu L
iScience
2026-07-31
|
#hepatocellular carcinoma
#drug discovery
#apoptosis
#anticancer
#hdac-inhibition
|
|
0
|
|
Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification.
(gut.bmj.com)
|
Yang G
…
Gao W
Gut
2026-07-28
|
#hepatocellular carcinoma
#glycosylation
#immunity
#t cell exhaustion
#immunotherapy
|
|
0
|
|
H3K18 lactylation drives CD8(+) T cell exclusion and anti-PD-1 resistance in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Zhu J
…
Wu H
Cell Reports
2026-07-28
|
#immunotherapy
#hepatocellular carcinoma
#epigenetics
#immunosuppression
#glycolysis
|